Pharmabiz52m
Philips accelerates precise imaging with unique AI technologies in MRI to improve patient outcomes
Philips accelerates precise imaging with unique AI technologies in MRI to improve patient outcomes: Amsterdam, The ...
Pharmabiz1h
US FDA grants priority review to Sobi’s sBLA for Gamifant for use in adult and paediatric patients with HLH/MAS in Still’s disease
US FDA grants priority review to Sobi’s sBLA for Gamifant for use in adult and paediatric patients with HLH/MAS in Still’s disease: Stockholm Friday, February 28, 2025, 09:00 ...
Pharmabiz2h
India’s screening for cervical cancer faces hesitance with social stigma and fear of positive result
India’s screening for cervical cancer faces hesitance with social stigma and fear of positive result: Nandita Vijayasimha Bengaluru Friday, February 28, 2025, 08:00 Hrs [IST] In ...
Pharmabiz2h
Interstate communication should be encouraged to stop cross border transportation of spurious drugs: Kamalasan Reddy
Interstate communication should be encouraged to stop cross border transportation of spurious drugs: Kamalasan Reddy: Peethaambaran Kunnathoor, Chennai Friday, February 28, 2025, ...
Pharmabiz2h
Indian pharma works on innovation & process development to cement its capability in APIs
Indian pharma works on innovation & process development to cement its capability in APIs: Nandita Vijayasimha, Bengaluru Friday, February 28, 2025, 08:00 Hrs [IST] Indian pharma h ...
Pharmabiz2h
ERS Summit emphasizes on advancing respiratory health in India
ERS Summit emphasizes on advancing respiratory health in India: Shardul Nautiyal, Mumbai Friday, February 28, 2025, 08:00 Hrs [IST] The European Respiratory Summit in Mumbai marke ...
Pharmabiz2h
DCGI asks manufacturers of two FDCs to submit applications within 3 months
DCGI asks manufacturers of two FDCs to submit applications within 3 months: Gireesh Babu, New Delhi Friday, February 28, 2025, 08:00 Hrs [IST] The Drugs Controller General of Indi ...
Pharmabiz19h
Lupin secures a place in the prestigious S&P Global Sustainability Yearbook 2025
Lupin secures a place in the prestigious S&P Global Sustainability Yearbook 2025: Our Bureau, Mumbai Thursday, February 27, ...
Pharmabiz16h
TNF Pharma begins phase 2b clinical trial to evaluate oral TNF-alpha inhibitor drug candidate isomyosamine
TNF Pharma begins phase 2b clinical trial to evaluate oral TNF-alpha inhibitor drug candidate isomyosamine: Baltimore Thursday, February 27, 2025, 18:00 Hrs [IST] TNF Pharmaceutic ...
Pharmabiz17h
Allogene Therapeutics expands collaboration with Foresight Diagnostics to advance development activities in Europe, UK, Canada & Australia
Allogene Therapeutics expands collaboration with Foresight Diagnostics to advance development activities in Europe, UK, Canada & Australia: South San Francisco, California Thursda ...
Pharmabiz19h
UK govt releases £25 mn for upgrades and refurbishments for hospices across England
UK govt releases £25 mn for upgrades and refurbishments for hospices across England: United Kingdom Thursday, February 27, 2025, 15:00 Hrs [IST] The UK government has confirmed t ...
Pharmabiz22h
Glenmark Pharma launches epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial
Glenmark Pharma launches epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial: Our Bureau, Mumbai Thursday, February 27, 2025, 12:30 Hrs [IST] Glenmark Pharmaceutic ...